연구동향 분석

Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter Observational Study in Korea

김진석 민유홍 정준원 신호진 이종욱 이제환 양덕환 이원식 김혁 박준성 김성현 김양수 곽재용 채의수 박진희 도영록 2014년

논문상세정보
인용/피인용
' Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter Observational Study in Korea' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • empiricalantifungaltherapy
  • hematologicalmalignancy
  • itraconazole
  • prognosis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,953 0

0.0%

' Clinical Outcomes and Prognostic Factors of Empirical Antifungal Therapy with Itraconazole in the Patients with Hematological Malignancies: A Prospective Multicenter Observational Study in Korea' 의 참고문헌

  • Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
    Walsh TJ N Engl J Med 346 225-234 [2002]
  • Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America
    Walsh TJ Clin Infect Dis 46 327-360 [2008]
  • The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study
    Pagano L Haematologica 91 1068-1075 [2006]
  • State of the art in the treatment of Hodgkin lymphoma
    Borchmann P Nat Rev Clin Oncol 9 450-459 [2012]
  • Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation
    Maertens J Blood 97 1604-1610 [2001]
  • Safety and efficacy of itraconazole compared to amphotericin B as empirical antifungal therapy for neutropenic fever in patients with haematological malignancy
    Schuler U Onkologie 30 185-191 [2007]
  • Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
    De Pauw B Clin Infect Dis 46 1813-1821 [2008]
  • Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
    Wingard JR Blood 116 5111-5118 [2010]
  • Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay
    Maertens JA Clin Infect Dis 44 1329-1336 [2007]
  • Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group
    Walsh TJ N Engl J Med 340 764-771 [1999]
  • Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
    Pagano L Haematologica 95 644-650 [2010]
  • Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial
    Boogaerts M Ann Intern Med 135 412-422 [2001]
  • Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
    Sun Hee Park The Korean Journal of Internal Medicine 21 3 165-172 [2006]
  • International staging system for multiple myeloma
    Greipp PR J Clin Oncol 23 3412-3420 [2005]
  • International scoring system for evaluating prognosis in myelodysplastic syndromes
    Greenberg P Blood 89 2079-2088 [1997]
  • Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective
    Tomblyn M Biol Blood Marrow Transplant 15 1143-1238 [2009]
  • Evidence-Based Guidelines for Empirical Therapy of Neutropenic Fever in Korea
    이동건 The Korean Journal of Internal Medicine 26 2 220-252 [2011]
  • European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update
    Maertens J Bone Marrow Transplant 46 709-718 [2011]
  • Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial
    Cordonnier C Clin Infect Dis 48 1042-1051 [2009]
  • Empirical antifungal therapy in treating febrile neutropenic patients
    Wingard JR Clin Infect Dis 39 Suppl 1 S38-S43 [2004]
  • Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group
    Am J Med 86 6 Pt 1 668-672 [1989]
  • Emergence of opportunistic mould infections in the hematopoietic stem cell transplant patient
    Upton A Curr Infect Dis Rep 8 434-441 [2006]
  • Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan
    Ohta K Int J Hematol 89 649-655 [2009]
  • Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus
    Ascioglu S Clin Infect Dis 34 7-14 [2002]
  • Common terminology criteria for adverse events (CTCAE) v3.0
    - [2006]
  • Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america
    Freifeld AG Clin Infect Dis 52 427-431 [2011]
  • Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
    Walsh TJ N Engl J Med 351 1391-1402 [2004]
  • Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole
    Glasmacher A Mycoses 42 443-451 [1999]
  • Antifungal therapy in patients with fever and neutropenia--more rational and less empirical?
    Klastersky J N Engl J Med 351 1445-1447 [2004]
  • A predictive model for aggressive non-Hodgkin’s lymphoma. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project
    N Engl J Med 329 987-994 [1993]